Top Tweets for #RogelinReview

over 3 years ago

We're looking back on our top stories of 2022! @carlkoschmann's team kept busy, discovering that a gene mutation in #Gliomas leads to cell cycle dysregulation and heightened sensitivity to a class of inhibitors. #RogelinReview https://t.co/5aiKwO2JLh

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back at our top stories of the year! So much innovative research came out of @CarlKoschmann's lab, including his team's work sampling spinal fluid to track treatment response in pediatric #Glioma #RogelinReview https://t.co/MbJQIx1669

499

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back on some of our top stories of 2022! One clinical trial gave us insight into new ways to address treatment resistance for #HeadAndNeckCancer — even though the trial failed. #RogelinReview https://t.co/CxYHXebTn6

525

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back at some of our top stories of 2022! A @NatureComms study by @AlumkalJoshi's lab suggested that a commonly used #ProstateCancer treatment rewires the engine of prostate tumors #RogelinReview https://t.co/aJc8xlOmvV

934

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

A lot of #BrainCancer research came out of #Rogel #BasicScience labs this year, including the discovery of oncostreams (active cells connected to how brain tumors grow and invade healthy tissue) by Pedro Lowenstein and @castro2355_mg #RogelinReview https://t.co/E4fh7b96df

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back at our top stories of 2022. @LaurenWallner showed us that chronic health conditions were associated with worse survival rates for patients with #Metastatic #BreastCancer, with Black women at the highest risk of death #RogelinReview https://t.co/lIW5NVV8fb

977

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back at our work in 2022! This year, we highlighted lots of different research about changes in #TumorMicroenvironment, including this Weiping Zou-led study that found a natural mechanism to sensitize #Cancer to #Immunotherapy #RogelinReview https://t.co/j1unYriUFj

564

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back at our top stories of 2022! Out of all the new content published this year, our feature on a #Glioblastoma clinical trial led by @DanWahlMD was the story with the second-highest number of pageviews on @MHealthLab. #RogelinReview https://t.co/LuRc1WmvRM

568

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back at some of our top stories of the year! One we loved was about this @UMLifeSciences research, which identified a hormone from fat cells that reprogrammed the liver #Microenvironment and restrained tumor growth in mice https://t.co/1d49HGeQ5Y #RogelinReview

699

U-M Rogel Cancer Center @UMRogelCancer

over 3 years ago

We're looking back on some of our top stories of 2022! The #TumorMicroenviroment came up again and again, with one study giving us new clues as to that microenvironment impacts pancreatic cancer #RogelinReview https://t.co/8E1Zkswo6r

Top Tweets for #RogelinReview

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users